. More recently, the development and availability of some biotinylated probes has allowed introduction of these assays into clinical laboratories without the attendant disadvantage of working with radioactive reagents (2, 4, 5, 7, 8, 9, 11 ,ul of HSV-1 and HSV-2 reagent. Shell vials were incubated at 36°C in a moist chamber for 30 min, and then the monolayers were washed twice in phosphate-buffered saline. The cover slips were removed from the vials, mounted (cell side down) on glass slides, and examined with a fluorescence microscope at x200 and x400 magnifications (6).
Specimens submitted for diagnosis of (4, 6) . Radiolabeled nucleic acid probes have been shown to be sensitive and specific for detection of both HSV and cytomegalovirus, but these reagents are not commercially available (1, 10, 14, 17, 18) . More recently, the development and availability of some biotinylated probes has allowed introduction of these assays into clinical laboratories without the attendant disadvantage of working with radioactive reagents (2, 4, 5, 7, 8, 9, 11 ,ul of HSV-1 and HSV-2 reagent. Shell vials were incubated at 36°C in a moist chamber for 30 min, and then the monolayers were washed twice in phosphate-buffered saline. The cover slips were removed from the vials, mounted (cell side down) on glass slides, and examined with a fluorescence microscope at x200 and x400 magnifications (6) .
(ii) DNA probe and peroxidase staining. Cells on cover slips were fixed in cold acetone for 5 min in shell vials. The acetone was aspirated, the cover slip was removed from the shell vial and mounted (cell side up) on a glass slide with a drop of clear nail polish as an adhesive. Biotinylated probe solution (1 drop, 0.025 ml) was added to the cell monolayer, and the slide was placed in a moist chamber and incubated in a water bath at 90°C for 30 min. The moist chamber was then placed in a 36°C incubator for 1 h to allow hybridization with the HSV probe. After the slide was washed with a solution of 0.015 M sodium citrate and 0.15 M sodium chloride (SSC), 0.1% Triton X100, and phosphate-buffered saline (for 2, 2, and 1 min, respectively), the cells were reacted with an avidin-horseradish peroxidase solution at 36°C for 30 min. The slide was then washed as previously described and then reacted with hydrogen peroxide and aminoethylcarbazole in acetate buffer for 5 min at room temperature. Cover slips were then washed in distilled water, counterstained for 1 min with fast green, and examined at x200 and x400 magnifi- (Table 1) . Of the 100 HSV strains detected in shell vials, 61 were HSV-2 and 39 were HSV-1. Of the 12 instances in which HSV was not detected by at least one test, the specimen was obtained from genital sites (10 of 12; 83%; 2 oral). Compared with conventional tube cell cultures, the sensitivities of nucleic acid hybridization and the monoclonal antibody and fluorescence assay in shell vials were 98 and 97%, respectively; both assays yielded specificities of 99%. Maximum detection of HSV (100 of 105; 95%) was obtained by both assays performed in shell vials, whereas 97 isolates (92%) were recovered in conventional tube cell cultures.
Positive reactions of the DNA probe assay were easily detected in monolayers on cover slips by the red-colored precipitate deposited almost exclusively in the nuclei of HSV-infected cells at 16 h postinoculation (Fig. 1) . The probe did not react with other members of the herpesvirus group, cytomegalovirus, and varicella-zoster virus that were similarly inoculated and stained in shell vials with the HSV probe assay.
DISCUSSION
Two previous studies have been reported that evaluated this DNA probe kit with clinical specimens. In the first report, HSV genome was detected by in situ hybridization in 16 (94%) of 17 stored human brain specimens that were previously positive for HSV by cell culture isolation (4). Further, the utility of in situ hybridization for detecting HSV in frozen tissue in this study was indicated by positive findings in six specimens that had negative immunofluorescence results after repeated testing. Fung et al. compared the utility of the commercial DNA probe with those of indirect immunofluorescence and cell culture for detecting HSV from genital, oral, ocular, and dermal sites (5). In their procedure, cells that remained in the specimen extract after cell culture inoculation were sedimented, suspended, and deposited on glass slides in preparation for nucleic acid hybridization and indirect immunofluorescence testing. Importantly, of the 243 specimens processed in their study, only 162 (67%) were We evaluated the HSV probe in a study design different from those of these two previous investigations. In our study, HSV in clinical specimens was amplified by inoculation and centrifugation in shell vial cell cultures for 16 h, after which the monolayers on cover slips were stained with monoclonal antibody or reacted with the DNA probe. In this system, deposition of precipitated stain subsequent to reaction with the probe kit components was clearly evident on intact HSV-infected cells in contrast to' a background of normal cells in a monolayer that were not stained. Interpretation of results was clear-cut. In addition, all 504 specimens received in our laboratory during this study wére acceptable for processing and not dependent on the number of intact cells remaining after centrifugation of specimen extracts as for the direct detection assay (5) .
Recovery of HSV in conventional tube cell cultures did not significantly differ from detection of HSV by nucleic acid hybridization or a monoclonal antibody and fluorescence assay in shell vials; nevertheless, both assay procedures in shell vials detected three more positive specimens than did the conventional tube cell cultures that required 2 or more days for 68 (70%) of 97 of the isolates to be recognized by characteristic cytopathic effects. Eight specimens that did not yield HSV in conventional tube cell cultures were positive in shell vials by either the fluorescence (monoclonal antibody) or hybridization (DNA probe) technique. The medical charts of only two of these patients were available for review; both had clinical evidence of HSV infection. Nevertheless, the high individual specificity of each method evaluated in this study was indicated by the agreement in results of 93 (93%) of 100 of the total positive specimens that agreed with a previous report from our laboratory (6) .
Specimen sources (genital, oral, dermal, and ocular) represent a cross section of sites that yield over 99% of the HSV routinely detected in clinical laboratories. Therefore, from a standpoint of the amount of virus present in each sample and the ability to detect low-titered samples, our study with 504 specimens should be representative of the usual workload in most laboratories. Conceivably, tissue specimens-particularly from the brain-may not 
